as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 29 Sep 2026
₹427.7
Change
-12.7 (-2.88%)
Open
₹437.0
Prev. Close
₹440.4
Day High
₹438.1
Day Low
₹426.0
Volume Analysis
Traded
74,365
Delivered
42,811
Delivery %
57.57%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (0)
No signal for this stock
Opportunities (0)
No signal for this stock
Threats (1)
- •FII holding has been falling
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹447.3 | ₹442.7 | ₹435.2 | ₹430.6 | ₹423.1 | ₹418.5 | ₹411.0 |
| Fibonacci | ₹442.7 | ₹438.08 | ₹435.22 | ₹430.6 | ₹425.98 | ₹423.12 | ₹418.5 |
| Camarilla | ₹431.03 | ₹429.92 | ₹428.81 | ₹430.6 | ₹426.59 | ₹425.48 | ₹424.37 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-26.15%
1 Week
-5.96%
1 Month
-11.84%
3 Months
-18.36%
6 Months
-0.09%
1 Year
-30.83%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹382.21
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
10.63%
Net margin 5.92% × asset turnover 1.05x × equity multiplier 1.71x
Company Overview
Sector
Chemicals
Market Cap
₹2,461 Cr
P/E (TTM)
16.3
ROE
10.8%
Book Value
₹241.0
Face Value
₹2.0
Source: Screener.in (Consolidated figures) — data as of 26 Sep 2026. Not investment advice.
TopFund Analysis
Rossari Biotech Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Chemicals sector, at 53/100. The strongest factor is Financial Strength (98/100), while Cash Flow (7/100) is the weakest area to weigh before deciding. FII holding has been falling.
TopFund Score — Fundamentals Quality
53/100 — AverageData confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 29 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- +Company's working capital requirements have reduced from 62.4 days to 48.6 days
- −Company has a low return on equity of 12.0% over last 3 years.
- −Dividend payout has been low at 2.00% of profits over last 3 years
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.
Rossari Biotech will not participate in Nirmal Bang’s investor conference on August 10, 2026.
Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 411 | 483 | 464 | 473 | 490 | 498 | 513 | 580 | 544 | 586 | 582 | 685 | 697 |
| Expenses + | 353 | 420 | 400 | 409 | 425 | 432 | 448 | 510 | 476 | 514 | 513 | 608 | 617 |
| Operating Profit | 58 | 64 | 64 | 64 | 65 | 66 | 65 | 69 | 68 | 72 | 69 | 77 | 81 |
| OPM % | 14.0% | 13.0% | 14.0% | 13.0% | 13.0% | 13.0% | 13.0% | 12.0% | 12.0% | 12.0% | 12.0% | 11.0% | 12.0% |
| Other Income + | 2 | 1 | 4 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 20 | 4 |
| Interest | 6 | 5 | 4 | 3 | 4 | 4 | 5 | 6 | 6 | 6 | 8 | 9 | 11 |
| Depreciation | 14 | 15 | 15 | 16 | 15 | 15 | 18 | 18 | 18 | 18 | 20 | 24 | 26 |
| Profit before tax | 39 | 45 | 48 | 46 | 47 | 48 | 42 | 48 | 46 | 50 | 43 | 64 | 48 |
| Tax % | 26.0% | 26.0% | 28.0% | 25.0% | 26.0% | 27.0% | 25.0% | 28.0% | 27.0% | 26.0% | 23.0% | 28.0% | 26.0% |
| Net Profit + | 29 | 33 | 34 | 34 | 35 | 35 | 32 | 34 | 34 | 37 | 33 | 46 | 35 |
| EPS in Rs | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 6 | 8 | 6 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Sales + | 516 | 600 | 709 | 1,483 | 1,656 | 1,831 | 2,080 | 2,396 | 2,550 |
| Expenses + | 438 | 495 | 586 | 1,299 | 1,433 | 1,581 | 1,815 | 2,110 | 2,251 |
| Operating Profit | 78 | 105 | 124 | 184 | 223 | 250 | 265 | 286 | 299 |
| OPM % | 15.0% | 17.0% | 17.0% | 12.0% | 13.0% | 14.0% | 13.0% | 12.0% | 12.0% |
| Other Income + | 1 | 4 | 9 | 13 | 6 | 8 | 5 | 24 | 26 |
| Interest | 3 | 4 | 3 | 13 | 22 | 19 | 18 | 29 | 34 |
| Depreciation | 12 | 17 | 23 | 48 | 63 | 60 | 67 | 79 | 87 |
| Profit before tax | 63 | 88 | 107 | 136 | 144 | 178 | 185 | 203 | 204 |
| Tax % | 28.0% | 26.0% | 25.0% | 28.0% | 26.0% | 26.0% | 26.0% | 26.0% | — |
| Net Profit + | 46 | 65 | 80 | 98 | 107 | 131 | 136 | 149 | 151 |
| EPS in Rs | 104 | 13 | 15 | 18 | 19 | 24 | 25 | 27 | 27 |
| Dividend Payout % | 0.0% | 4.0% | 3.0% | 3.0% | 3.0% | 2.0% | 2.0% | 2.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Reserves | 119 | 277 | 398 | 794 | 904 | 1,037 | 1,174 | 1,322 |
| Borrowings + | 8 | 67 | 0 | 8 | 74 | 119 | 218 | 436 |
| Other Liabilities + | 118 | 118 | 152 | 442 | 375 | 401 | 482 | 505 |
| Total Liabilities | 250 | 471 | 561 | 1,255 | 1,364 | 1,567 | 1,886 | 2,274 |
| Fixed Assets + | 74 | 94 | 181 | 607 | 585 | 578 | 598 | 784 |
| CWIP | 3 | 22 | 0 | 1 | 16 | 47 | 140 | 173 |
| Investments | 0 | 18 | 0 | 36 | 51 | 63 | 84 | 62 |
| Other Assets + | 173 | 338 | 379 | 611 | 712 | 880 | 1,063 | 1,254 |
| Total Assets | 250 | 471 | 561 | 1,255 | 1,364 | 1,567 | 1,886 | 2,274 |
| Equity Capital | 4 | 10 | 10 | 11 | 11 | 11 | 11 | 11 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 71 | 57 | 48 | 29 | 152 | 43 | 137 | 65 |
| Cash from Investing Activity + | -37 | -190 | -37 | -299 | -181 | -103 | -183 | -220 |
| Cash from Financing Activity + | -29 | 157 | -25 | 292 | 61 | 16 | 65 | 186 |
| Net Cash Flow | 5 | 23 | -14 | 22 | 32 | -44 | 19 | 31 |
| CFO/OP | 118 | 74 | 64 | 43 | 89 | 39 | 74 | 47 |
| Free Cash Flow | 27 | -19 | -8 | -7 | 120 | -83 | -21 | -175 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 8.23% | 9.45% | 9.9% | 10.98% | 10.64% | 10.6% | 10.24% | 10.5% | 10.95% | 11.25% | 11.46% | 15.19% |
| Promoters | 68.35% | 68.34% | 68.32% | 68.32% | 68.27% | 68.19% | 68.18% | 68.18% | 68.18% | 68.15% | 68.15% | 68.14% |
| FII | 5.74% | 4.14% | 4.02% | 3.83% | 3.74% | 3.74% | 3.98% | 3.48% | 2.7% | 2.32% | 2.18% | 2.03% |
| DII | 17.68% | 18.06% | 17.74% | 16.87% | 17.34% | 17.47% | 17.59% | 17.84% | 18.18% | 18.25% | 18.21% | 14.64% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Chemicals — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Rossari Biotech Limited (this stock) | 2,461 | 16.3 | 1.84 | 10.8% |
| J.g.chemicals Limited | 2,555 | 34.0 | 4.83 | 13.3% |
| Bodal Chemicals Ltd | 2,563 | 37.3 | 2.21 | 1.97% |
| Gsp Crop Science Limited | 2,184 | 20.9 | 2.83 | 16.5% |
| S H Kelkar And Co. Ltd. | 1,971 | 41.7 | 1.44 | 3.71% |
| Thirumalai Chemicals Ltd | 1,940 | — | 1.24 | -11.8% |
| Steamhouse India Limited | 3,034 | 78.5 | — | 25.3% |
Which Mutual Funds Hold Rossari Biotech Limited?
Frequently Asked Questions about Rossari Biotech Limited
Rossari Biotech Limited (ROSSARI) closed at ₹427.7 on NSE on 29 September 2026, down 12.7 (2.88%) from the previous close.
Rossari Biotech Limited trades on the NSE (National Stock Exchange of India) under the symbol ROSSARI.
Rossari Biotech Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 16.3.
Rossari Biotech Limited has a dividend yield of 0.11%.
Rossari Biotech Limited's 52-week high is ₹691.0 and its 52-week low is ₹373.0.
Rossari Biotech Limited has a market capitalisation of ₹2,461 crore.
Rossari Biotech Limited has a TopFund Quality Score of 53/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Rossari Biotech Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.